Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.

Saved in:
Bibliographic Details
Title: Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.
Authors: Uboha NV; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA., Basree MM; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Eickhoff JC; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Deming DA; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA., Matkowskyj K; William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Maloney J; William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.; Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., McCarthy D; Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., DeCamp M; Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., LoConte N; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA., Emmerich PB; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Kraus S; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Patel MA; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA., Kratz JD; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA.; William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA.; Center for Human Genomics and Precision Medicine, University of Wisconsin, Madison, Wisconsin, USA., Lubner SJ; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, Madison, Wisconsin, USA., Hurst N; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Bassetti MF; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Source: Journal of surgical oncology [J Surg Oncol] 2025 Jun; Vol. 131 (7), pp. 1293-1301. Date of Electronic Publication: 2025 Jan 05.
Publication Type: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-9098
DOI:10.1002/jso.28070